Symbol:
PANX1
Name:
pannexin 1
RGD ID:
1347653
HGNC Page
HGNC:8599
Description:
Enables several functions, including ATP transmembrane transporter activity; channel activity; and identical protein binding activity. Involved in ATP transport; calcium ion transport; and positive regulation of interleukin-1 beta production. Located in several cellular components, including bleb; endoplasmic reticulum; and gap junction. Implicated in depressive disorder.
Type:
protein-coding
RefSeq Status:
REVIEWED
Previously known as:
innexin; MGC21309; MRS1; OOMD7; OZEMA7; pannexin-1; PX1; UNQ2529
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Mus musculus (house mouse):
Panx1 (pannexin 1)
HGNC
EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Rattus norvegicus (Norway rat):
Panx1 (Pannexin 1)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther, PhylomeDB, Treefam
Chinchilla lanigera (long-tailed chinchilla):
Panx1 (pannexin 1)
NCBI
Ortholog
Pan paniscus (bonobo/pygmy chimpanzee):
PANX1 (pannexin 1)
NCBI
Ortholog
Canis lupus familiaris (dog):
PANX1 (pannexin 1)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Panx1 (pannexin 1)
NCBI
Ortholog
Sus scrofa (pig):
PANX1 (pannexin 1)
HGNC
Ensembl, Inparanoid, NCBI, OrthoDB
Chlorocebus sabaeus (green monkey):
PANX1 (pannexin 1)
NCBI
Ortholog
Heterocephalus glaber (naked mole-rat):
Panx1 (pannexin 1)
NCBI
Ortholog
Alliance orthologs 3
Rattus norvegicus (Norway rat):
Panx1 (Pannexin 1)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Panx1 (pannexin 1)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
panx1a (pannexin 1a)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid|ZFIN)
Danio rerio (zebrafish):
panx1b (pannexin 1b)
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|ZFIN)
Xenopus tropicalis (tropical clawed frog):
panx1
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER|PhylomeDB)
Xenopus laevis (African clawed frog):
panx1.L
Alliance
DIOPT (Xenbase)
Xenopus laevis (African clawed frog):
panx1.S
Alliance
DIOPT (Xenbase)
Allele / Splice:
See ClinVar data
Latest Assembly:
GRCh38 - Human Genome Assembly GRCh38
Position:
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 11 94,128,841 - 94,181,968 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 11 94,128,841 - 94,181,968 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 11 93,862,007 - 93,915,134 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 11 93,501,742 - 93,554,786 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 11 93,501,741 - 93,554,783 NCBI Celera 11 91,149,894 - 91,202,958 (+) NCBI Celera Cytogenetic Map 11 q21 NCBI HuRef 11 89,937,250 - 89,990,295 (+) NCBI HuRef CHM1_1 11 93,745,100 - 93,798,158 (+) NCBI CHM1_1 T2T-CHM13v2.0 11 94,045,617 - 94,098,852 (+) NCBI T2T-CHM13v2.0
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
PANX1 Human 1,2-dimethylhydrazine multiple interactions ISO RGD:1552235 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PANX1 mRNA CTD PMID:22206623 PANX1 Human 17alpha-ethynylestradiol increases expression ISO RGD:735204 6480464 Ethinyl Estradiol results in increased expression of PANX1 mRNA CTD PMID:29097150 PANX1 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:735204 6480464 Tetrachlorodibenzodioxin results in increased expression of PANX1 mRNA CTD PMID:33387578 PANX1 Human 3'-O-(4-Benzoyl)benzoyl ATP decreases activity ISO RGD:1552235 6480464 3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate results in decreased activity of PANX1 protein CTD PMID:19023039 PANX1 Human 4,4'-diaminodiphenylmethane increases expression ISO RGD:1552235 6480464 4,4'-diaminodiphenylmethane results in increased expression of PANX1 mRNA CTD PMID:18648102 PANX1 Human 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid decreases activity ISO RGD:1552235 6480464 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid results in decreased activity of PANX1 protein CTD PMID:19023039 PANX1 Human 4-Acetamido-4'-isothiocyanostilbene-2,2'-disulphonic acid decreases activity ISO RGD:1552235 6480464 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid results in decreased activity of PANX1 protein CTD PMID:19023039 PANX1 Human 4-hydroxyphenyl retinamide increases expression ISO RGD:1552235 6480464 Fenretinide results in increased expression of PANX1 mRNA CTD PMID:28973697 PANX1 Human 5-Nitro-2-(3-phenylpropylamino)benzoic acid decreases activity ISO RGD:1552235 6480464 5-nitro-2-(3-phenylpropylamino)benzoic acid results in decreased activity of PANX1 protein CTD PMID:19023039 PANX1 Human aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of PANX1 protein CTD PMID:20106945 PANX1 Human aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of PANX1 mRNA CTD PMID:27153756 PANX1 Human aflatoxin B1 decreases methylation EXP 6480464 Aflatoxin B1 results in decreased methylation of PANX1 gene CTD PMID:27153756 PANX1 Human arsane multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 PANX1 Human arsenic atom multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 PANX1 Human ATP decreases activity EXP 6480464 Adenosine Triphosphate results in decreased activity of PANX1 protein CTD PMID:19023039 PANX1 Human ATP decreases activity ISO RGD:1552235 6480464 Adenosine Triphosphate results in decreased activity of PANX1 protein CTD PMID:19023039 PANX1 Human ATP multiple interactions EXP 6480464 Carbenoxolone inhibits the reaction [PANX1 protein results in increased export of Adenosine Triphosphate]; Probenecid inhibits more ... CTD PMID:19213873 PANX1 Human ATP increases export EXP 6480464 PANX1 protein results in increased export of Adenosine Triphosphate CTD PMID:19213873 PANX1 Human atrazine affects methylation ISO RGD:735204 6480464 Atrazine affects the methylation of PANX1 gene CTD PMID:28931070 PANX1 Human benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of PANX1 mRNA CTD PMID:26238291|PMID:32234424 PANX1 Human benzo[a]pyrene diol epoxide I decreases expression EXP 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PANX1 mRNA CTD PMID:19150397|PMID:20382639 PANX1 Human bisphenol A decreases expression ISO RGD:735204 6480464 bisphenol A results in decreased expression of PANX1 mRNA CTD PMID:25181051 PANX1 Human bisphenol A decreases methylation EXP 6480464 bisphenol A results in decreased methylation of PANX1 gene CTD PMID:31601247 PANX1 Human bisphenol A increases expression ISO RGD:735204 6480464 bisphenol A results in increased expression of PANX1 mRNA CTD PMID:29097150 PANX1 Human cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PANX1 more ... CTD PMID:35301059 PANX1 Human cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PANX1 more ... CTD PMID:35301059 PANX1 Human carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of PANX1 mRNA CTD PMID:25979313 PANX1 Human CARBENOXOLONE decreases activity ISO RGD:1552235 6480464 Carbenoxolone results in decreased activity of PANX1 protein CTD PMID:19023039 PANX1 Human CARBENOXOLONE multiple interactions EXP 6480464 Carbenoxolone inhibits the reaction [PANX1 protein results in increased export of Adenosine Triphosphate] CTD PMID:19213873 PANX1 Human carbon nanotube increases expression ISO RGD:1552235 6480464 Nanotubes, Carbon results in increased expression of PANX1 mRNA; Nanotubes, Carbon results in increased expression more ... CTD PMID:25554681|PMID:32413421 PANX1 Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to PANX1 gene] CTD PMID:28238834 PANX1 Human chlorpyrifos decreases expression ISO RGD:1552235 6480464 Chlorpyrifos results in decreased expression of PANX1 mRNA CTD PMID:37019170 PANX1 Human choline multiple interactions ISO RGD:1552235 6480464 [Dietary Fats co-treated with Choline deficiency] results in increased expression of PANX1 mRNA; [Methionine deficiency more ... CTD PMID:20938992|PMID:29246445 PANX1 Human cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of PANX1 mRNA CTD PMID:27392435 PANX1 Human copper(II) chloride increases expression EXP 6480464 cupric chloride results in increased expression of PANX1 mRNA CTD PMID:38568856 PANX1 Human copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of PANX1 mRNA CTD PMID:19549813 PANX1 Human crocidolite asbestos affects expression EXP 6480464 Asbestos, Crocidolite affects the expression of PANX1 mRNA CTD PMID:24160326 PANX1 Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of PANX1 mRNA CTD PMID:20106945 PANX1 Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of PANX1 mRNA CTD PMID:29803840 PANX1 Human ethanol multiple interactions ISO RGD:1552235 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of PANX1 mRNA CTD PMID:30517762 PANX1 Human ethyl methanesulfonate increases expression EXP 6480464 Ethyl Methanesulfonate results in increased expression of PANX1 mRNA CTD PMID:23649840 PANX1 Human flufenamic acid decreases activity ISO RGD:1552235 6480464 Flufenamic Acid results in decreased activity of PANX1 protein CTD PMID:19023039 PANX1 Human folic acid multiple interactions ISO RGD:1552235 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PANX1 mRNA; [Methionine deficiency co-treated more ... CTD PMID:20938992|PMID:22206623 PANX1 Human folpet decreases expression ISO RGD:1552235 6480464 folpet results in decreased expression of PANX1 mRNA CTD PMID:31558096 PANX1 Human formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of PANX1 mRNA CTD PMID:23649840 PANX1 Human glutathione decreases oxidation ISO RGD:1552235 6480464 PANX1 gene mutant form results in decreased oxidation of Glutathione CTD PMID:29246445 PANX1 Human GTP decreases activity ISO RGD:1552235 6480464 Guanosine Triphosphate results in decreased activity of PANX1 protein CTD PMID:19023039 PANX1 Human hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of PANX1 mRNA CTD PMID:20044591 PANX1 Human L-methionine multiple interactions ISO RGD:1552235 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... CTD PMID:20938992 PANX1 Human leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of PANX1 mRNA CTD PMID:28988120 PANX1 Human lipopolysaccharide increases expression ISO RGD:1552235 6480464 Lipopolysaccharides results in increased expression of PANX1 mRNA CTD PMID:22147977 PANX1 Human manganese atom multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 PANX1 Human manganese(0) multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 PANX1 Human manganese(II) chloride multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 PANX1 Human menadione increases expression ISO RGD:1552235 6480464 Vitamin K 3 results in increased expression of PANX1 mRNA CTD PMID:25270620 PANX1 Human methyl methanesulfonate increases expression EXP 6480464 Methyl Methanesulfonate results in increased expression of PANX1 mRNA CTD PMID:23649840 PANX1 Human N-nitrosodiethylamine increases expression ISO RGD:1552235 6480464 Diethylnitrosamine results in increased expression of PANX1 mRNA CTD PMID:24535843 PANX1 Human nickel atom increases expression EXP 6480464 Nickel results in increased expression of PANX1 mRNA CTD PMID:24768652|PMID:25583101 PANX1 Human Niflumic acid decreases activity ISO RGD:1552235 6480464 Niflumic Acid results in decreased activity of PANX1 protein CTD PMID:19023039 PANX1 Human nitrates multiple interactions ISO RGD:1552235 6480464 [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PANX1 more ... CTD PMID:35964746 PANX1 Human okadaic acid increases expression EXP 6480464 Okadaic Acid results in increased expression of PANX1 mRNA CTD PMID:38832940 PANX1 Human oxaliplatin multiple interactions ISO RGD:735204 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PANX1 mRNA CTD PMID:25729387 PANX1 Human paracetamol affects expression ISO RGD:1552235 6480464 Acetaminophen affects the expression of PANX1 mRNA CTD PMID:17562736 PANX1 Human paracetamol increases expression ISO RGD:735204 6480464 Acetaminophen results in increased expression of PANX1 mRNA CTD PMID:33387578 PANX1 Human paracetamol affects localization ISO RGD:1552235 6480464 Acetaminophen affects the localization of PANX1 protein CTD PMID:27826632 PANX1 Human paracetamol increases expression ISO RGD:1552235 6480464 Acetaminophen results in increased expression of PANX1 mRNA CTD PMID:27826632|PMID:29246445 PANX1 Human paracetamol multiple interactions ISO RGD:1552235 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in decreased expression of AADAT mRNA]; more ... CTD PMID:27826632|PMID:29246445 PANX1 Human paracetamol affects response to substance ISO RGD:1552235 6480464 PANX1 gene mutant form affects the susceptibility to Acetaminophen CTD PMID:29246445 PANX1 Human paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PANX1 mRNA CTD PMID:21420995 PANX1 Human perfluorooctanoic acid increases expression ISO RGD:735204 6480464 perfluorooctanoic acid results in increased expression of PANX1 mRNA CTD PMID:35163327 PANX1 Human phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of PANX1 mRNA CTD PMID:19159669 PANX1 Human probenecid multiple interactions EXP 6480464 Probenecid inhibits the reaction [PANX1 protein results in increased export of Adenosine Triphosphate] CTD PMID:19213873 PANX1 Human probenecid decreases activity ISO RGD:1552235 6480464 Probenecid results in decreased activity of PANX1 protein CTD PMID:19023039 PANX1 Human resveratrol multiple interactions EXP 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of PANX1 mRNA CTD PMID:23557933 PANX1 Human serpentine asbestos affects expression EXP 6480464 Asbestos, Serpentine affects the expression of PANX1 mRNA CTD PMID:24160326 PANX1 Human sodium arsenite affects methylation EXP 6480464 sodium arsenite affects the methylation of PANX1 gene CTD PMID:28589171 PANX1 Human sodium arsenite decreases expression ISO RGD:1552235 6480464 sodium arsenite results in decreased expression of PANX1 mRNA CTD PMID:37682722 PANX1 Human sodium arsenite multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 PANX1 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of PANX1 mRNA CTD PMID:38568856 PANX1 Human tacrolimus hydrate increases expression ISO RGD:1552235 6480464 Tacrolimus results in increased expression of PANX1 mRNA CTD PMID:29362864 PANX1 Human testosterone increases expression ISO RGD:1552235 6480464 Testosterone results in increased expression of PANX1 mRNA CTD PMID:20403060 PANX1 Human tetrachloromethane increases expression ISO RGD:1552235 6480464 Carbon Tetrachloride results in increased expression of PANX1 mRNA CTD PMID:29987408 PANX1 Human tetrachloromethane multiple interactions ISO RGD:1552235 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of PANX1 mRNA; [PANX1 protein co-treated more ... CTD PMID:29987408|PMID:30517762 PANX1 Human topotecan multiple interactions ISO RGD:735204 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PANX1 mRNA CTD PMID:25729387 PANX1 Human trichloroethene increases expression ISO RGD:735204 6480464 Trichloroethylene results in increased expression of PANX1 mRNA CTD PMID:33387578 PANX1 Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of PANX1 mRNA CTD PMID:37042841 PANX1 Human UTP decreases activity ISO RGD:1552235 6480464 Uridine Triphosphate results in decreased activity of PANX1 protein CTD PMID:19023039 PANX1 Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of PANX1 mRNA CTD PMID:25979313
1,2-dimethylhydrazine (ISO) 17alpha-ethynylestradiol (ISO) 2,3,7,8-tetrachlorodibenzodioxine (ISO) 3'-O-(4-Benzoyl)benzoyl ATP (ISO) 4,4'-diaminodiphenylmethane (ISO) 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid (ISO) 4-Acetamido-4'-isothiocyanostilbene-2,2'-disulphonic acid (ISO) 4-hydroxyphenyl retinamide (ISO) 5-Nitro-2-(3-phenylpropylamino)benzoic acid (ISO) aflatoxin B1 (EXP) arsane (EXP) arsenic atom (EXP) ATP (EXP,ISO) atrazine (ISO) benzo[a]pyrene (EXP) benzo[a]pyrene diol epoxide I (EXP) bisphenol A (EXP,ISO) cadmium atom (EXP) cadmium dichloride (EXP) carbamazepine (EXP) CARBENOXOLONE (EXP,ISO) carbon nanotube (ISO) CGP 52608 (EXP) chlorpyrifos (ISO) choline (ISO) cisplatin (EXP) copper(II) chloride (EXP) copper(II) sulfate (EXP) crocidolite asbestos (EXP) cyclosporin A (EXP) doxorubicin (EXP) ethanol (ISO) ethyl methanesulfonate (EXP) flufenamic acid (ISO) folic acid (ISO) folpet (ISO) formaldehyde (EXP) glutathione (ISO) GTP (ISO) hydrogen peroxide (EXP) L-methionine (ISO) leflunomide (EXP) lipopolysaccharide (ISO) manganese atom (EXP) manganese(0) (EXP) manganese(II) chloride (EXP) menadione (ISO) methyl methanesulfonate (EXP) N-nitrosodiethylamine (ISO) nickel atom (EXP) Niflumic acid (ISO) nitrates (ISO) okadaic acid (EXP) oxaliplatin (ISO) paracetamol (EXP,ISO) perfluorooctanoic acid (ISO) phenobarbital (EXP) probenecid (EXP,ISO) resveratrol (EXP) serpentine asbestos (EXP) sodium arsenite (EXP,ISO) tacrolimus hydrate (ISO) testosterone (ISO) tetrachloromethane (ISO) topotecan (ISO) trichloroethene (ISO) triphenyl phosphate (EXP) UTP (ISO) valproic acid (EXP)
PANX1 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 11 94,128,841 - 94,181,968 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 11 94,128,841 - 94,181,968 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 11 93,862,007 - 93,915,134 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 11 93,501,742 - 93,554,786 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 11 93,501,741 - 93,554,783 NCBI Celera 11 91,149,894 - 91,202,958 (+) NCBI Celera Cytogenetic Map 11 q21 NCBI HuRef 11 89,937,250 - 89,990,295 (+) NCBI HuRef CHM1_1 11 93,745,100 - 93,798,158 (+) NCBI CHM1_1 T2T-CHM13v2.0 11 94,045,617 - 94,098,852 (+) NCBI T2T-CHM13v2.0
Panx1 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 9 14,917,081 - 14,956,774 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 9 14,913,424 - 14,956,774 (-) Ensembl GRCm39 Ensembl GRCm38 9 15,005,785 - 15,045,478 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 9 15,002,128 - 15,045,478 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 9 14,810,229 - 14,849,922 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 9 14,756,178 - 14,795,871 (-) NCBI MGSCv36 mm8 Celera 9 12,286,408 - 12,326,356 (-) NCBI Celera Cytogenetic Map 9 A2 NCBI cM Map 9 4.52 NCBI
Panx1 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 8 20,128,783 - 20,171,200 (-) NCBI GRCr8 mRatBN7.2 8 11,851,176 - 11,889,774 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 8 11,850,730 - 11,889,774 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 8 15,835,505 - 15,873,902 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 8 14,133,250 - 14,171,653 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 8 12,114,170 - 12,153,042 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 8 13,567,185 - 13,606,040 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 8 13,566,739 - 13,606,040 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 8 13,508,401 - 13,547,151 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 8 11,809,752 - 11,849,392 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 8 11,809,751 - 11,849,392 (-) NCBI Celera 8 13,320,676 - 13,358,794 (-) NCBI Celera Cytogenetic Map 8 q12 NCBI
Panx1 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955414 401,188 - 448,470 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955414 405,483 - 448,470 (-) NCBI ChiLan1.0 ChiLan1.0
PANX1 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 9 94,981,323 - 95,136,371 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 11 96,074,806 - 96,126,726 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 11 89,142,686 - 89,295,972 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 11 92,628,760 - 92,685,118 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 11 92,628,760 - 92,685,109 (+) Ensembl panpan1.1 panPan2
PANX1 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 21 6,665,730 - 6,715,272 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 21 6,668,269 - 6,715,858 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 21 6,675,643 - 6,724,808 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 21 6,846,046 - 6,895,302 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 21 6,846,046 - 6,895,402 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 21 6,626,593 - 6,676,016 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 21 6,695,903 - 6,745,264 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 21 6,746,177 - 6,795,582 (-) NCBI UU_Cfam_GSD_1.0
Panx1 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
PANX1 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 9 26,443,815 - 26,491,002 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 9 26,443,425 - 26,491,010 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 9 30,047,789 - 30,182,476 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
PANX1 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 1 85,356,507 - 85,413,146 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 1 85,356,610 - 85,409,275 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666043 40,394,937 - 40,454,501 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Panx1 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 1195 Count of miRNA genes: 496 Interacting mature miRNAs: 533 Transcripts: ENST00000227638, ENST00000436171 Prediction methods: Microtar, Miranda, Rnahybrid Result types: miRGate_prediction
597245851 GWAS1341925_H aspartate aminotransferase measurement QTL GWAS1341925 (human) 7e-49 aspartate aminotransferase measurement blood aspartate aminotransferase activity level (CMO:0000580) 11 94132981 94132982 Human 597255130 GWAS1351204_H serum alanine aminotransferase measurement QTL GWAS1351204 (human) 2e-83 serum alanine aminotransferase measurement serum alanine aminotransferase activity level (CMO:0000575) 11 94137172 94137173 Human 597102675 GWAS1198749_H aspartate aminotransferase measurement QTL GWAS1198749 (human) 9e-38 aspartate aminotransferase measurement blood aspartate aminotransferase activity level (CMO:0000580) 11 94131227 94131228 Human 597605786 GWAS1662646_H aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1662646 (human) 6e-58 aspartate aminotransferase to alanine aminotransferase ratio serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) 11 94132981 94132982 Human 597081426 GWAS1177500_H autoimmune thyroid disease QTL GWAS1177500 (human) 5e-09 autoimmune thyroid disease 11 94179870 94179871 Human 597166864 GWAS1262938_H serum alanine aminotransferase measurement QTL GWAS1262938 (human) 8e-65 serum alanine aminotransferase measurement serum alanine aminotransferase activity level (CMO:0000575) 11 94137172 94137173 Human 596957532 GWAS1077051_H thyroid peroxidase antibody measurement QTL GWAS1077051 (human) 9e-09 thyroid peroxidase antibody measurement 11 94179870 94179871 Human 597598167 GWAS1655027_H aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1655027 (human) 4e-32 aspartate aminotransferase to alanine aminotransferase ratio serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) 11 94131227 94131228 Human 597293203 GWAS1389277_H serum alanine aminotransferase measurement QTL GWAS1389277 (human) 5e-12 serum alanine aminotransferase measurement serum alanine aminotransferase activity level (CMO:0000575) 11 94179870 94179871 Human 597343383 GWAS1439457_H serum alanine aminotransferase measurement QTL GWAS1439457 (human) 2e-94 serum alanine aminotransferase measurement serum alanine aminotransferase activity level (CMO:0000575) 11 94131227 94131228 Human 597204183 GWAS1300257_H upper aerodigestive tract neoplasm QTL GWAS1300257 (human) 0.0000002 upper aerodigestive tract neoplasm 11 94143496 94143497 Human 597143943 GWAS1240017_H serum alanine aminotransferase measurement QTL GWAS1240017 (human) 3e-40 serum alanine aminotransferase measurement serum alanine aminotransferase activity level (CMO:0000575) 11 94179870 94179871 Human 597182281 GWAS1278355_H pyruvate measurement QTL GWAS1278355 (human) 4e-08 pyruvate measurement blood pyruvate level (CMO:0002422) 11 94135658 94135659 Human 597328392 GWAS1424466_H eosinophil measurement QTL GWAS1424466 (human) 4e-12 eosinophil measurement 11 94128854 94128855 Human 597168714 GWAS1264788_H aspartate aminotransferase measurement QTL GWAS1264788 (human) 6e-44 aspartate aminotransferase measurement blood aspartate aminotransferase activity level (CMO:0000580) 11 94131227 94131228 Human 597599052 GWAS1655912_H serum alanine aminotransferase measurement QTL GWAS1655912 (human) 2e-83 serum alanine aminotransferase measurement serum alanine aminotransferase activity level (CMO:0000575) 11 94132981 94132982 Human 597301570 GWAS1397644_H serum alanine aminotransferase measurement QTL GWAS1397644 (human) 5e-40 serum alanine aminotransferase measurement serum alanine aminotransferase activity level (CMO:0000575) 11 94131227 94131228 Human 597243905 GWAS1339979_H serum alanine aminotransferase measurement QTL GWAS1339979 (human) 2e-86 serum alanine aminotransferase measurement serum alanine aminotransferase activity level (CMO:0000575) 11 94132981 94132982 Human 597301440 GWAS1397514_H serum alanine aminotransferase measurement QTL GWAS1397514 (human) 2e-30 serum alanine aminotransferase measurement serum alanine aminotransferase activity level (CMO:0000575) 11 94137172 94137173 Human 597142029 GWAS1238103_H aspartate aminotransferase measurement QTL GWAS1238103 (human) 2e-23 aspartate aminotransferase measurement blood aspartate aminotransferase activity level (CMO:0000580) 11 94180526 94180527 Human 597105611 GWAS1201685_H Thyroid preparation use measurement QTL GWAS1201685 (human) 5e-11 Thyroid preparation use measurement 11 94178690 94178691 Human 597618307 GWAS1675167_H Abnormality of the liver QTL GWAS1675167 (human) 9e-18 Abnormality of the liver 11 94132981 94132982 Human 596986996 GWAS1106515_H serum alanine aminotransferase measurement QTL GWAS1106515 (human) 5e-12 serum alanine aminotransferase measurement 11 94179870 94179871 Human 597099253 GWAS1195327_H aspartate aminotransferase measurement QTL GWAS1195327 (human) 5e-12 aspartate aminotransferase measurement blood aspartate aminotransferase activity level (CMO:0000580) 11 94180526 94180527 Human 597103985 GWAS1200059_H serum alanine aminotransferase measurement QTL GWAS1200059 (human) 7e-55 serum alanine aminotransferase measurement serum alanine aminotransferase activity level (CMO:0000575) 11 94137172 94137173 Human 597311152 GWAS1407226_H Thyroid preparation use measurement QTL GWAS1407226 (human) 2e-11 Thyroid preparation use measurement 11 94176914 94176915 Human 597599149 GWAS1656009_H serum alanine aminotransferase measurement QTL GWAS1656009 (human) 6e-68 serum alanine aminotransferase measurement serum alanine aminotransferase activity level (CMO:0000575) 11 94132981 94132982 Human 597168622 GWAS1264696_H aspartate aminotransferase measurement QTL GWAS1264696 (human) 9e-13 aspartate aminotransferase measurement blood aspartate aminotransferase activity level (CMO:0000580) 11 94179472 94179473 Human 597060206 GWAS1156280_H hypothyroidism QTL GWAS1156280 (human) 6e-09 hypothyroidism 11 94179472 94179473 Human 597606373 GWAS1663233_H aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1663233 (human) 7e-44 aspartate aminotransferase to alanine aminotransferase ratio serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) 11 94132981 94132982 Human 597062056 GWAS1158130_H squamous cell lung carcinoma QTL GWAS1158130 (human) 0.000004 squamous cell lung carcinoma 11 94143496 94143497 Human
SHGC-149437
Human Assembly Chr Position (strand) Source JBrowse GRCh37 11 93,908,462 - 93,908,756 UniSTS GRCh37 Build 36 11 93,548,110 - 93,548,404 RGD NCBI36 Celera 11 91,196,282 - 91,196,576 RGD Cytogenetic Map 11 q21 UniSTS HuRef 11 89,983,619 - 89,983,913 UniSTS TNG Radiation Hybrid Map 11 43369.0 UniSTS
WIAF-1483
Human Assembly Chr Position (strand) Source JBrowse GRCh37 11 93,914,923 - 93,915,073 UniSTS GRCh37 Build 36 11 93,554,571 - 93,554,721 RGD NCBI36 Celera 11 91,202,743 - 91,202,893 RGD Cytogenetic Map 11 q21 UniSTS HuRef 11 89,990,080 - 89,990,230 UniSTS GeneMap99-GB4 RH Map 11 315.21 UniSTS NCBI RH Map 11 791.6 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
entire extraembryonic component
1204
2439
2788
2253
4973
1726
2351
6
624
1950
465
2269
7305
6471
53
3734
1
852
1744
1617
175
1
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENST00000227638 ⟹ ENSP00000227638
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 11 94,128,841 - 94,181,968 (+) Ensembl
Ensembl Acc Id:
ENST00000436171 ⟹ ENSP00000411461
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 11 94,128,929 - 94,181,966 (+) Ensembl
RefSeq Acc Id:
NM_015368 ⟹ NP_056183
RefSeq Status:
REVIEWED
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 11 94,128,841 - 94,181,968 (+) NCBI GRCh37 11 93,862,094 - 93,918,762 (+) NCBI Build 36 11 93,501,742 - 93,554,786 (+) NCBI Archive HuRef 11 89,937,250 - 89,990,295 (+) ENTREZGENE CHM1_1 11 93,745,100 - 93,798,158 (+) NCBI T2T-CHM13v2.0 11 94,045,617 - 94,098,852 (+) NCBI
Sequence:
GTACTTGGTTTCCCCGCATGGTTCCGGAAGAGCGCGGCGCAGCTGGCTGTGAGCGCAGGGCTATCCCGGCGGCCGCTTCGGCAGCCAGGGCGGCGCGGAGGGGCAGGGCCAGAGGGAAGCGCTTTGTT CCGCGCGTGGTTCCCGCGCCTGGGGGTGCGCGGGAGAGGCGCGAATCCGAGTGCCGCGCGCGGCCCGGGGACTTGCACGGGCGTGCGGGGTGGAACCGCAGGAAGCGGAGCTCTCGGGTTCCCGCCCC GCCCCGCCCCGCCGGCGGCGGAGGCAGCGAGCGCGAGAGCCCAGCGGAGTCGCTGGGAGCCTGAGGCACCGAGACACAAAGGCAGGCGGGATGCGGGAGCAGGCAAAGGGAAAGCGAAAGCCGCGCGC CCGGCCGGTGACTGGGTGAAGGCGCCGCGCAGCTTTCCCGACGCCGGCTGTACCCGGACCTCCTGGTCGAGCCTGGCGCGCCGCAGCCATGGCCATCGCTCAACTGGCCACGGAGTACGTGTTCTCGG ATTTCTTGCTGAAGGAGCCCACGGAGCCCAAGTTCAAGGGGCTGCGACTGGAGCTGGCTGTGGACAAGATGGTCACGTGCATTGCGGTGGGGCTGCCCCTGCTGCTCATCTCGCTGGCCTTCGCGCAG GAGATCTCGATTGGTACACAGATAAGCTGTTTCTCTCCAAGTTCTTTCTCCTGGCGTCAGGCTGCCTTTGTGGATTCATATTGCTGGGCGGCTGTTCAGCAGAAGAACTCACTGCAGAGCGAGTCTGG AAACCTCCCACTGTGGCTGCATAAGTTTTTCCCCTACATCCTGCTGCTCTTTGCGATCCTCCTGTACCTGCCCCCGCTGTTCTGGCGTTTCGCAGCTGCTCCTCATATTTGCTCAGACTTGAAGTTTA TCATGGAAGAACTTGACAAAGTTTACAACCGTGCAATTAAGGCTGCAAAGAGTGCGCGTGACCTTGACATGAGAGATGGAGCCTGCTCAGTTCCAGGTGTTACCGAGAACTTAGGGCAAAGTTTGTGG GAGGTATCTGAAAGCCACTTCAAGTACCCAATTGTGGAGCAGTACTTGAAGACAAAGAAAAATTCTAATAATTTAATCATCAAGTACATTAGCTGCCGCCTGCTGACACTCATCATTATACTGTTAGC GTGTATCTACCTGGGCTATTACTTCAGCCTCTCCTCACTCTCAGACGAGTTTGTGTGCAGCATCAAATCAGGGATCCTGAGAAACGACAGCACCGTGCCCGATCAGTTTCAGTGCAAACTCATTGCCG TGGGCATCTTCCAGTTGCTCAGTGTCATTAACCTTGTGGTTTATGTCCTGCTGGCTCCCGTGGTTGTCTACACGCTGTTTGTTCCATTCCGACAGAAGACAGATGTTCTCAAAGTGTACGAAATCCTC CCCACTTTTGATGTTCTGCATTTCAAATCTGAAGGGTACAACGATTTGAGCCTCTACAATCTCTTCTTGGAGGAAAATATAAGTGAGGTCAAGTCATACAAGTGTCTTAAGGTACTGGAGAATATTAA GAGCAGTGGTCAGGGGATCGACCCAATGCTACTCCTGACAAACCTTGGCATGATCAAGATGGATGTTGTTGATGGCAAAACTCCCATGTCTGCAGAGATGAGAGAGGAGCAGGGGAACCAGACGGCAG AGCTCCAAGGTATGAACATAGACAGTGAAACTAAAGCAAATAATGGAGAGAAGAATGCCCGACAGAGACTTCTGGATTCTTCTTGCTGATGATTTTTTTCCTTGAGCTGTAAATCTGTGACTTCTGCG ACATGGGATTTAATTTGGCTAAAGCACCCCTGTTGGTTTCACAGCTGGTTTGCAATAAATGGTTCTTGGTGGAGATACTGAGCATGTCTTATTGAGTCCCTAATGGAAATGGTGATCAACAAAAGGTT ATGGAAGAATGGTTTATGAACTTCCCATAGGAAGCACCTGAGAGATAGTAAACTGCAGCAAGTAACTATGTGTAAGTCCTCATCAAATGAAAAGCAGAAAGACAAGAACAATTAGTCAAGAGCAGTAG CCCTGTCAGAGCCTCGGAGCAATACCTTTCTGTACCCGTGGTGAGACAAGACCCAGAGCTACTGGAAAACAAGCACTTTGGAAGATTTGTTTTGTTTTCATGGAATAATAATATGTCAGGGTATAATT TAACGTGAGTTTCTTATGTGCCCTTAAAGACTGTTAGACAAGAAAAGCATTCACTGGCTAATAATCCATAGGTCGACCTATGTCCTAAGTTAGGTGTAAGGTCCGATGCCTTGGCCCACACTCGAGCT CTCTTTACATTGTTAGTTGTCAACCTTGGCTGATGGAAATCCCGTAACCACTATTTGTTGCACTGTGCCTTGAAGGGCAGCAGGCCCAAGTGCTGCTCTGACTGAAAACTGAGTTAACAAGATGAAAT CTAAAGGATATTCACAGTGACTTCAATTCAGGAAGAATGCTTCCAAAAGAGCCCAGTGGGGAAATCTGACATCACAGAAGACATTAATTCAGTCACTTTCAAAGAGTTTGTCTACAGGCGGTTTCTCT GTTATCAAAGGCATTTGAAATAGGATTTTACTTAAACAATAATGGAACACAGGAGTATTTAAAGTGAAGAACACTTTGCCTGAATGTGATCAGGGCACATAAGTGACATTGGCATGCTTCATATGGCG TGCTTGGAGCCAGAAAAACTTAGCGGTTTATTTTGTTTATATTTAAGCACAGCTTTAAAAAATTCATTATCGTTTATTCAGTGTCCGAATTGAGGCCATTTGGGAAGAAAATTCTAGCACTGGTGGAG AATTATAGAATAAAGATTATAAATGGTTGGATAAGA
hide sequence
RefSeq Acc Id:
XM_011542734 ⟹ XP_011541036
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 11 94,153,563 - 94,181,968 (+) NCBI
Sequence:
CTGGGCGGCTGTTCAGCAGAAGAACTCACTGCAGAGCGAGTCTGGAAACCTCCCACTGTGGCTG CATAAGGCTTGTTCATTTACCTTGGTGCTCTGGATGAGTGAGAATTCAACAGACAAACACGGAGGAAAGGATTCCAAGCAGAGGAAAGAGGATTCCAAAGGGCCACAGAGCCAGCTATGAATTATGCA GCCAAAATTCAGCTAATCACAGCCTGCTTTGTGTGTCATTGTGTAGCAGCCCTTTGCAAATTGGGTTAATACTTTTGAAACACCTCATCCCGTGCCAGAATGCCAAAGTAAAGCAGCTGTCTTGTTTT TCCCCTACATCCTGCTGCTCTTTGCGATCCTCCTGTACCTGCCCCCGCTGTTCTGGCGTTTCGCAGCTGCTCCTCATATTTGCTCAGACTTGAAGTTTATCATGGAAGAACTTGACAAAGTTTACAAC CGTGCAATTAAGGCTGCAAAGAGTGCGCGTGACCTTGACATGAGAGATGGAGCCTGCTCAGTTCCAGGTGTTACCGAGAACTTAGGGCAAAGTTTGTGGGAGGTATCTGAAAGCCACTTCAAGTACCC AATTGTGGAGCAGTACTTGAAGACAAAGAAAAATTCTAATAATTTAATCATCAAGTACATTAGCTGCCGCCTGCTGACACTCATCATTATACTGTTAGCGTGTATCTACCTGGGCTATTACTTCAGCC TCTCCTCACTCTCAGACGAGTTTGTGTGCAGCATCAAATCAGGGATCCTGAGAAACGACAGCACCGTGCCCGATCAGTTTCAGTGCAAACTCATTGCCGTGGGCATCTTCCAGTTGCTCAGTGTCATT AACCTTGTGGTTTATGTCCTGCTGGCTCCCGTGGTTGTCTACACGCTGTTTGTTCCATTCCGACAGAAGACAGATGTTCTCAAAGTGTACGAAATCCTCCCCACTTTTGATGTTCTGCATTTCAAATC TGAAGGGTACAACGATTTGAGCCTCTACAATCTCTTCTTGGAGGAAAATATAAGTGAGGTCAAGTCATACAAGTGTCTTAAGGTACTGGAGAATATTAAGAGCAGTGGTCAGGGGATCGACCCAATGC TACTCCTGACAAACCTTGGCATGATCAAGATGGATGTTGTTGATGGCAAAACTCCCATGTCTGCAGAGATGAGAGAGGAGCAGGGGAACCAGACGGCAGAGCTCCAAGGTATGAACATAGACAGTGAA ACTAAAGCAAATAATGGAGAGAAGAATGCCCGACAGAGACTTCTGGATTCTTCTTGCTGATGATTTTTTTCCTTGAGCTGTAAATCTGTGACTTCTGCGACATGGGATTTAATTTGGCTAAAGCACCC CTGTTGGTTTCACAGCTGGTTTGCAATAAATGGTTCTTGGTGGAGATACTGAGCATGTCTTATTGAGTCCCTAATGGAAATGGTGATCAACAAAAGGTTATGGAAGAATGGTTTATGAACTTCCCATA GGAAGCACCTGAGAGATAGTAAACTGCAGCAAGTAACTATGTGTAAGTCCTCATCAAATGAAAAGCAGAAAGACAAGAACAATTAGTCAAGAGCAGTAGCCCTGTCAGAGCCTCGGAGCAATACCTTT CTGTACCCGTGGTGAGACAAGACCCAGAGCTACTGGAAAACAAGCACTTTGGAAGATTTGTTTTGTTTTCATGGAATAATAATATGTCAGGGTATAATTTAACGTGAGTTTCTTATGTGCCCTTAAAG ACTGTTAGACAAGAAAAGCATTCACTGGCTAATAATCCATAGGTCGACCTATGTCCTAAGTTAGGTGTAAGGTCCGATGCCTTGGCCCACACTCGAGCTCTCTTTACATTGTTAGTTGTCAACCTTGG CTGATGGAAATCCCGTAACCACTATTTGTTGCACTGTGCCTTGAAGGGCAGCAGGCCCAAGTGCTGCTCTGACTGAAAACTGAGTTAACAAGATGAAATCTAAAGGATATTCACAGTGACTTCAATTC AGGAAGAATGCTTCCAAAAGAGCCCAGTGGGGAAATCTGACATCACAGAAGACATTAATTCAGTCACTTTCAAAGAGTTTGTCTACAGGCGGTTTCTCTGTTATCAAAGGCATTTGAAATAGGATTTT ACTTAAACAATAATGGAACACAGGAGTATTTAAAGTGAAGAACACTTTGCCTGAATGTGATCAGGGCACATAAGTGACATTGGCATGCTTCATATGGCGTGCTTGGAGCCAGAAAAACTTAGCGGTTT ATTTTGTTTATATTTAAGCACAGCTTTAAAAAATTCATTATCGTTTATTCAGTGTCCGAATTGAGGCCATTTGGGAAGAAAATTCTAGCACTGGTGGAGAATTATAGAATAAAGATTATAAATGGTTG GATAAGACAAATGTAAGCTTATTTCATAAACATTTAAAGCTGATTCAGAACATGTTAAAAACTGTTCCCAATTCCAACTATGTAAATAGATCCTATGTTCACATTTTACACACACACACAAAAATCTT TAACATCTGTGGAACTTCCCAGTTTTAGTCTTAGAAAGTTAGCATGTTGCATAAGTTCAGTAATCCTCAGGAACCTCCAAGTTTACTTTTAGCTCTTACGGACAGTTGTTTACATAATCTAATTACTG TTTTCTGAAGAACGGAAATTATATAAGCTGCTGTCTGCCTTTTGGAATATTCAGAAAAGCAGATTTTATTTGTACTTCTGTGATGTTTTCTGAAATGGAAAGCTGATGATAAATATCAAAGTAGCAAT CAGTGCGTTAAATTATTCTGTTACATGATATTTATTACTGTTGAATTATTCTGTGACTTAGAAATGGCAGTAACCTAAATAATGGAATTTGCAAAATTATTATATTGCCGTATCTGAGATGTTCCATC ACAAGTTTCTACACTGGTTTCTTTTGAAAATTTAAAAAGATTTACGAGATACATTTTCTAGGATATGATTTTTTTTTTACAAAAAGCTTCATCTTCTGTAGACTATCCTTAATTTCTATTTTGAAACG GTAAAAATTGATATTTTAGGACACCAGGAAGTCTCCAAGCCATTCCCACTCTCTGAACTCCAGTAGGGTCTGTGATGTCCCAGGCACCAGTACCAAGTTGGATGTGCAGATATGCATAGGCAGGTCCC ATCCTTGAGGACTTCAGAGTCCAGTAAAAGGCAGCAGAAACATGGGCTGGTGCCTAAGAGGAGAAAGCGTAGCCACAGTAAAGGCTATGCCAGAAAACTCCTAGCAAATGCTCTGTGTTCTTGGGAGA GGGCACATTGTTTTTGTTTTCTCTCCTATAGTTCCTGTAACTGCTGGTTTTGAGAATATAGTAATCATTTTTCCCAGAGGCAGATGACCACCTTAAGGTTCTTTAGCTGCAAATCCTCTAGGTTGAAG TTTGTGTGAAATAGTCACAGTGATTTTGAATAGTAAGGAATCCAGTTGCCTTTTGAACCTTCCCTCACAGGGATGAGAGAACAAGCCTGTGGAGGTTGTGGAGCTACTGGTAAACAACTGTCAGGGCC CCAGAAGGCTGATGTGGAGGCCTGGGGATACATTTCATCTAATAAAAGTATTACTAGGTATCAGTATCAGTAATAAAAGTATTATAATAAAGTATCAGTAATAAAAGTATTATAATAAAAAGTATTAT TAGGACAGGTAAACTCATCCATCTACTGTGAGCTGCTGGCTTGGAGAACGACTTTTGAGGAGCCAGTTTCCTGAGGAGAAATGCTTTTATAAAGCACTCATTGCTTTGTAAAAGGAGACAAAACTGAT CCTAAATGACCACTCCAGGGTTGCTGATTTTGTTTCTGGCTCATGTCTGCCTAGTAAACCACCAGCAAGCTGCTGAACCAGGCTGGAAACAACATTGTTGCAACTGGGAGGGACATAGAGTACTGTGA AAGCAGCGTTCCAACACATCTTCACTTTTACAAAGGGATAGGCAGAGACTTCCAACATAGAGGTTCTTAAACTTCGAGGGGTTACAATCCCCTTGCAAATATTTTTATAGCTATGGACCCTCTCCTCA GATCTACAGCCAACATTTTCAGTGCACCTTAGGAGGTCATTTTAGTCCACGCCTCTGAAAAAGCTGCACTCCAACGGCTGAAGAGCAAGCCATACGGCCGAGAATGGGGCTCCCTTTGCCTTCATGAA AGCTACTTCCCCCAACACTAAGACTCAGCTGTACGTTTGCTTAGCTCAGTCACATTTACATTCTTCTGGGTGAACTGTACCTTTTGAGTACCTGCCTTCATTTTCTAGAATCAGACCTAACAAGGTCA GTAGAAGCCTGGGCAGCAGCAGGCCTGGAAAGACGAGGCAGCCAGCATGAACTGCTGTTCTCTCCCTGACCACAAGGCGTCGTCTTCCTCCAGGGTCAAGTAATTGTTCTTGTTCCGCCTCACAGGAA TGTGGGGAGGAAGGACGTAACACTATAAAATGCTGCGTCCTACCTTAAACTTGTACTGTGAGAAAGCTGGAAACTTCCACCTGTACAGTGGGTCTGGTTTGCATGTTTAGTTTCATTTGTGGGAACTG CTTGTCCAAGAGTGAGCTCAGGTCAGGGCAGTTTGTGCCTATGAGAATTAGCTCAGCTATCAGGCAGGTTTTTAGACACCTTTTTAAAATGTGCTCGTGTTTGGTTTGTTTTGCTTACTGTCAGTCCT GGGTCAATCAAAGGTTTGTAAGGGTGAGAATTTTTATGCACTGCTATATCGCAAGTGCTTAAAACAGAGACTGGCCCAGATGAGGCATTCTTCAAATGTTTGTTGAAATGAATGGACAAACTCTTAGG ATAAATCCTAATTTGTTGGCAACTGTTATTTGATTTTAGAAGGCAAACTGATTTTATTTTAGAGAGGGGAAGGGGAGGGGAGGCTCATTAGCCTCTTGGTAGAAAGAGGACTATTTCTGCAAATGAAT AGGTTTCCACCTTAAGTAGTGACAGTCCTTAACTTCTTATTATGGAGTGAGTCTTGACCGCTTTCCAAGTTCAATAGAAGTTCAAGATTGCCTCTCAGTGATTAGGGAAATTGAAGCTTTTAAAGCTC CTGGTCTCAGTAATTCCTCAGAATAAACCTCTTTAAAAGGGATATTGATGGAAATGTACAATTACCAGTAATTGAGGTTTTATCTGAGGGGATGGAGATGATGAAATGGTTCCTTCTTGGAAGTTGTT GGCATTTTGGCTTTATTTTTCACAAATAAAGTGAAACCATTTAAAACGATTGACAACGATTATATAGTGCCATGTGGAATACAATAGATATTAATTTGTGGTTGGTTTTTCTGCCTGCTTTAAATGAA ATGTATTATGTTTCTGGGTTCCTTTTTTAGCTGTAAAAATACTTCGTCACTAAAGCATGAAATTTAATCAGCAGTTGTTCTTCAAGTTCCTGAAAGCTATAAAAGTTTCTCATGACTTGAGTGGTTTT TTCCCTGCCCACCAGAGGAGAAAGCCCTTGTAGAATTCTGCAGTGTTACAAGTGTTCCCTACAAAAACTGAAACCATCAGCTCCTCTTTAACAAGTTGGCTTTTTAAAAGCACGTAATTACAATTTAA TGGTATTCTGTAAAGTGGTGCTTTAGGCATAATTTAAATTCTTTTTAATGACTATATTTCTTCAAAACTTTGAAAGAAAAATGTGTTCTTTTTGCTGCATCCTTTGTAAGAAGACTGCCAACAGAGGA AAAAGGACTTTACAAATTAAGACCATCTTGGTTTCATTTCCACAAAGATGAGAACAAATCATGGTGTTAGGAAAGGATCCTTAGAAGAACACAAGAATTTGAAAGCCCTTGGTGGTTATCACTACTAT ATTTCATATTTCCACAGAAGTGACTTAGCCAAGCTCTGCATTTTGAGCCTGCTGACTTTCATTTAAAAGGAATGAAAGGCTGAAAATCCAGGCTGCTGTGTCTGTAGATAAAGGTCAAACCATGTTTG AGTTCTTCACTGTTGTGTCCACCTAAATAAAACTGAGTAAGTAATGAAAAA
hide sequence
RefSeq Acc Id:
XM_047426702 ⟹ XP_047282658
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 11 94,153,549 - 94,181,968 (+) NCBI
RefSeq Acc Id:
XM_054368280 ⟹ XP_054224255
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 11 94,070,447 - 94,098,852 (+) NCBI
RefSeq Acc Id:
XM_054368281 ⟹ XP_054224256
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 11 94,070,433 - 94,098,852 (+) NCBI
RefSeq Acc Id:
NP_056183 ⟸ NM_015368
- UniProtKB:
Q96L77 (UniProtKB/Swiss-Prot), Q96AM9 (UniProtKB/Swiss-Prot), Q6UW26 (UniProtKB/Swiss-Prot), Q543A0 (UniProtKB/Swiss-Prot), O75968 (UniProtKB/Swiss-Prot), Q96RS5 (UniProtKB/Swiss-Prot), Q96RD7 (UniProtKB/Swiss-Prot), B6ETL5 (UniProtKB/TrEMBL)
- Sequence:
MAIAQLATEYVFSDFLLKEPTEPKFKGLRLELAVDKMVTCIAVGLPLLLISLAFAQEISIGTQISCFSPSSFSWRQAAFVDSYCWAAVQQKNSLQSESGNLPLWLHKFFPYILLLFAILLYLPPLFWR FAAAPHICSDLKFIMEELDKVYNRAIKAAKSARDLDMRDGACSVPGVTENLGQSLWEVSESHFKYPIVEQYLKTKKNSNNLIIKYISCRLLTLIIILLACIYLGYYFSLSSLSDEFVCSIKSGILRND STVPDQFQCKLIAVGIFQLLSVINLVVYVLLAPVVVYTLFVPFRQKTDVLKVYEILPTFDVLHFKSEGYNDLSLYNLFLEENISEVKSYKCLKVLENIKSSGQGIDPMLLLTNLGMIKMDVVDGKTPM SAEMREEQGNQTAELQGMNIDSETKANNGEKNARQRLLDSSC
hide sequence
RefSeq Acc Id:
XP_011541036 ⟸ XM_011542734
- Peptide Label:
isoform X1
- Sequence:
MEELDKVYNRAIKAAKSARDLDMRDGACSVPGVTENLGQSLWEVSESHFKYPIVEQYLKTKKNS NNLIIKYISCRLLTLIIILLACIYLGYYFSLSSLSDEFVCSIKSGILRNDSTVPDQFQCKLIAVGIFQLLSVINLVVYVLLAPVVVYTLFVPFRQKTDVLKVYEILPTFDVLHFKSEGYNDLSLYNLF LEENISEVKSYKCLKVLENIKSSGQGIDPMLLLTNLGMIKMDVVDGKTPMSAEMREEQGNQTAELQGMNIDSETKANNGEKNARQRLLDSSC
hide sequence
Ensembl Acc Id:
ENSP00000227638 ⟸ ENST00000227638
Ensembl Acc Id:
ENSP00000411461 ⟸ ENST00000436171
RefSeq Acc Id:
XP_047282658 ⟸ XM_047426702
- Peptide Label:
isoform X1
RefSeq Acc Id:
XP_054224256 ⟸ XM_054368281
- Peptide Label:
isoform X1
RefSeq Acc Id:
XP_054224255 ⟸ XM_054368280
- Peptide Label:
isoform X1
RGD ID: 6789201
Promoter ID: HG_KWN:13970
Type: CpG-Island
SO ACC ID: SO:0000170
Source: MPROMDB
Tissues & Cell Lines: CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, HeLa_S3, K562, Lymphoblastoid, NB4
Transcripts: NM_015368, UC001PEQ.2
Position: Human Assembly Chr Position (strand) Source Build 36 11 93,501,459 - 93,501,959 (+) MPROMDB
RGD ID: 7221831
Promoter ID: EPDNEW_H16661
Type: initiation region
Name: PANX1_1
Description: pannexin 1
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_H16662
Experiment Methods: Single-end sequencing.; Paired-end sequencing.
Position: Human Assembly Chr Position (strand) Source GRCh38 11 94,128,874 - 94,128,934 EPDNEW
RGD ID: 7221833
Promoter ID: EPDNEW_H16662
Type: initiation region
Name: PANX1_2
Description: pannexin 1
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_H16661
Experiment Methods: Single-end sequencing.
Position: Human Assembly Chr Position (strand) Source GRCh38 11 94,129,145 - 94,129,205 EPDNEW